Skip to main content

Clinical Trials › NCT04956744

RecruitingPhase 1

A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis

Sponsored by ImStem Biotechnology

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
30
Target enrollment
3
U.S. states
Aug 2021
Start date
Dec 2027
Expected completion

Interventions / Treatments

IMS001

Conditions studied

Multiple Sclerosis

Where this trial is running (3 sites)

Georgia1 site
Atlanta
Worcester
Utah1 site
Salt Lake City

Participating MS centers on MS Buddy (3)

MS centers in Georgia

Compare treatment centers near a trial site by center type, providers and trials.

View Georgia centers

More Phase 1 trials

Browse all Phase 1 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play